Profil
Andreas Maetzel served as Vice President-Global Medical Affairs at BioCryst Pharmaceuticals, Inc. from 2014 to 2017.
Prior to that, he was VP-Clinical Development & Regulatory Affairs at Cornerstone Therapeutics, Inc. from 2013 to 2014.
He also worked as Senior Vice President-Medical at KalVista Pharmaceuticals, Inc. Dr. Maetzel holds a graduate and doctorate degree from the University of Toronto and a doctorate degree from the University of Hannover.
Anciens postes connus de Andreas Maetzel
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2017 |
| CORNERSTONE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2014 |
| KALVISTA PHARMA | Directeur Technique/Scientifique/R&D | - |
Formation de Andreas Maetzel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hannover
University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
















